On September 19, 2019, the first post-marketing implantation of the VitaFlow^® Valve System and Alwide^® Balloon in Lingnan Region was successfully performed by the team of Prof. Luo Jianfang at Guangdong General Hospital.

Shanghai, China - on August 28, 2019, the first implantation of the self-developed VitaFlow^® Transcatheter Aortic Valve System of MicroPort^® Cardioflow was performed at Zhongshan Hospital affiliated to Fudan University. Prof. Ge Junbo, Academician of Chinese Academy of Sciences, Director of the Cardiology Department of Zhongshan Hospital, performed the surgery and successfully implanted the VitaFlow^® aortic valve into a 70-year-old male patient.

In Shanghai, China on December 12, 2018, the self-developed VitaFlow^® II Transcatheter Aortic Valve and Recyclable Delivery System of MicroPort^® Cardioflow has been admitted into the “Green Path”from National Medical Products Administration (NMPA) for the special approval procedure for innovative medical devices.